Marvel Biosciences Corp (MRVL : TSX-V)
Common Stock
$0.15
CAD
-0.01 (-3.23%)
Last updated: 2026-08-21
Get MRVL alerts:
MRVL
Marvel Biosciences Corp
WealthAwesomePerformance
1 Day
-3.23%
1 Week
-11.76%
1 Month
-6.25%
YTD
+11.11%
Key Statistics
Market Cap
$9.45M
52W High
$0.40
52W Low
$0.12
P/E Ratio
-
50 Day MA
$0.17
200 Day MA
$0.16
Beta
0.59
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 8/21/2026 | $0.17 | $0.17 | $0.15 | $0.15 | $0.15 | 18,112 |
| 8/20/2026 | $0.15 | $0.17 | $0.15 | $0.15 | $0.15 | 44,356 |
| 8/19/2026 | $0.17 | $0.17 | $0.16 | $0.17 | $0.17 | 47,185 |
| 8/18/2026 | $0.17 | $0.17 | $0.16 | $0.16 | $0.16 | 12,111 |
| 8/17/2026 | $0.17 | $0.17 | $0.14 | $0.16 | $0.16 | 187,950 |
| 8/14/2026 | $0.17 | $0.17 | $0.17 | $0.17 | $0.17 | 58,000 |
| 8/13/2026 | $0.16 | $0.16 | $0.15 | $0.16 | $0.16 | 18,000 |
| 8/12/2026 | $0.17 | $0.17 | $0.16 | $0.16 | $0.16 | 8,500 |
| 8/11/2026 | $0.17 | $0.17 | $0.16 | $0.17 | $0.17 | 26,700 |
| 8/10/2026 | $0.17 | $0.17 | $0.15 | $0.17 | $0.17 | 31,608 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MRVL's historical volatility
30-Day Vol
89.6%
Annualized
90-Day Vol
131.6%
Annualized
Trend (90d)
-13.8%
Annualized drift
90d Mean
C$0.14
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.15 | C$0.11 – C$0.20 |
| 60 trading days | C$0.15 | C$0.09 – C$0.22 |
| 90 trading days | C$0.14 | C$0.08 – C$0.24 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Marvel Biosciences Corp
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-2.19M
- Profit Margin
- 0.00%
- ROE (TTM)
- -380.30%
- EPS (Diluted)
- -0.03
- Book Value
- -0.04
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About MRVL
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| IRI | IEMR Resources Inc | $0.01 | +100.00% |
| PLY | Playfair Mining Ltd. | $0.09 | +63.64% |
| JADE | Jade Leader Corp | $0.01 | +50.00% |
| DELX | DelphX Capital Markets Inc | $0.01 | +50.00% |
| ATOM | Atomic Minerals Corp | $0.03 | +50.00% |
| GGAU | Galactic Gold Corp. | $0.19 | +35.71% |
| PTE | Pioneering Technology Corp | $0.02 | +33.33% |
| KIP | Kiplin Metals Inc | $0.27 | +32.50% |
MRVL.V news timeline
5 articles covering MRVL.V, most recent first
Latest